Trial intelligence / Profile preview

The CORE Study: Chemotherapy vs Endocrine Treatment First in Advanced Breast Cancer

NCT00403182Phase 3Withdrawn

Sponsor
Technical University of Munich
Start
May 2006
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of letrozole in breast cancer, sponsored by Technical University of Munich. Planned start May 2006; status: withdrawn.

02

Drugs

letrozole
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00403182.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00403182.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call